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Abstract
Background: Previous comparative proteomic analysis on Plasmodium falciparum isolates of different adhesion
properties suggested that protein phosphorylation varies between isolates with different cytoadherence
properties. But the extent and dynamic changes in phosphorylation have not been systematically studied. As a
baseline for these future studies, this paper examined changes in the phosphoproteome of parasitized red blood
cells (pRBC).
Methods: Metabolic labelling with [35S] methionine on pRBC and 2D gel electrophoresis (2-DE) has previously
been used to show the expression of parasite proteins and changes in protein iso-electric point (PI). 2-DE of
different parasite strains was combined with immunoblotting using monoclonal antibodies specifically to
phosphorylated serine/threonine and tyrosine, to obtain the phosphorylation profiles throughout the erythrocytic
lifecycle. Affinity chromatography was used to purify/enrich phosphorylated proteins and these proteins from
mature trophozoite stages which were identified using high-accuracy mass spectrometry and MASCOT search.
Results: 2D-immunoblots showed that P. falciparum infection greatly increased phosphorylation of a set of
proteins in pRBC, the dominant size classes for phosphorylated tyrosine proteins were 95, 60, 50 and 30 kDa and
for phosphorylated serine/threonine were 120, 95, 60, 50, 43, 40 and 30 kDa. The most abundant molecules from
2D-gel mapping of phosphorylated proteins in ItG infected RBCs were identified by MALDI-TOF. A proteomic
overview of phosphorylated proteins in pRBC was achieved by using complementary phosphorylated protein
enrichment techniques combined with nano-flow LC/MS/MS analysis and MASCOT MS/MS ions search with
phosphorylation as variable modifications. The definite phosphoproteins of pRBC are reported and discussed.
Conclusion: Protein phosphorylation is a major process in P. falciparum-parasitized erythrocytes. Preliminary
screens identified 170 P. falciparum proteins and 77 human proteins as phosphorylated protein in pRBC, while
only 48 human proteins were identified in the corresponding fractions from uninfected RBC. Refinement of the
search to include significant ion scores indicating a specific phospho-peptide identified 21 P. falciparum proteins
and 14 human proteins from pRBC, 13 host proteins were identified from normal RBC. The results achieved by
complementary techniques consistently reflect a reliable proteomic overview of pRBC.
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Phosphorylation-dephosphorylation is the major control
mechanism for many cellular functions, including the reg-
ulation of cell division, protein synthesis and transcrip-
tion [1]. Phosphorylation determines many functions of
proteins (e.g. enzymes, microtubules, histones and tran-
scription factors) and regulates signal transduction to con-
trol cellular responses to a particular stimulation.
Phosphorylation often occurs on multiple distinct sites on
a given protein [2] and this multi-layer control magnifies
the final signal and promotes sensitive regulation. In a
study by Ptacek et al using proteome chip technology to
determine the in vitro substrates recognized by the major-
ity of yeast protein kinases, 4,192 phosphorylation events
involving 1,325 different proteins were identified.
Approximately one third of all eukaryotic proteins are
phosphorylated [3,4]. This represents a broad spectrum of
different biochemical functions and cellular roles. Since
many yeast proteins and pathways are conserved, these
results provide insights into the mechanisms and roles of
protein phosphorylation in many eukaryotes.
Protein phosphorylation has been shown to be an impor-
tant event in malaria infection. For example, Plasmodium
falciparum infection leads to a dramatic increase in the
phosphorylation level of erythrocyte protein 4.1 which
forms a tight complex with the mature parasite-infected
erythrocyte surface antigens [5-7]. The 11 N-terminal
amino acids of membrane-associated band 3 are critical
for tyrosine phosphorylation and deletion of these amino
acids greatly reduced the ability of parasite invasion [8].
By using [g-32P] ATP and [32P] orthophosphate labelling
combined with 2-DE analysis, Suetterlin et al have identi-
fied 59 P. falciparum specific phospho-proteins with
molecular weights between 15 and 192 kDa in pRBC [9],
including two HSP70 heat shock proteins, Pf-hsp and Pf-
grp [10]. Plasmodium falciparum infection causes the
plasma membrane of erythrocytes to become increasingly
permeable to a variety of physiologically relevant solutes
via the induction of new permeation pathways (NPPs)
which is also thought to involve phosphorylation [11].
Approximately 100 kinases have been identified in the P.
falciparum genome, represent 1.1–1.6% of the protein-
coding genes of malaria parasite [12,13] and there is great
interest in them as potential targets for drugs based on
chemical inhibitors [14]. Examples of P. falciparum phos-
phorylation activity include a calcium-dependent protein
kinase that prefers phosphorylation of proteins of the host
erythrocytic membrane but very few parasite proteins [15]
and P. falciparum phosphatases such as protein phos-
phatase 1 (PP1), which is responsible for regulation of the
phosphorylation status of the membrane protein PfSBP1
[16]. As inhibitors of protein kinases and phosphatases
can interfere with parasite growth [17], it is suggested that
studies in this area may contribute to the development of
novel therapies for malaria.
Severe malaria is believed to be caused by adhesion of P.
falciparum pRBC in the small blood vessels of major
organs [18]. This processes involved in the reaction of sev-
eral parasite ligands with endothelium receptors, mainly,
PfEMP1 [19-22], ICAM-1 [23] and CD36 [24,25]. Protein
phosphorylation has also been shown to relate to cell
adherence events. In epithelial cells, tyrosine phosphor-
ylation of cadherins and their associated proteins has
major effects on the stability of adhesion junctions [26].
Alteration of tyrosine phosphorylation status is associated
with the expression of tyrosine kinase receptor K-sam,
which may cause the cytoplasmic distribution of cad-
herin-catenin molecules and loose cell-cell adhesion in
undifferentiated-type gastric cancers [27]. In malaria,
CD36 ectodomain phosphorylation at Thr92 can regulate
pRBC adhesion to CD36 and to human dermal microvas-
cular endothelial cells (HDMECs) under flow conditions,
and is regulated by a Src family kinase- and alkaline phos-
phatase dependent mechanism [28]. Lucchi et al demon-
strated that pRBC cytoadherence to syncytiotrophoblast
via chondroitin sulphate A (CSA) enhanced tyrosine
phosphorylation of 93 kDa and 85 kDa proteins in these
cells [29], but whether the phosphorylation was on pro-
tein of pRBC or BeWo cells has not been determined.
Interestingly, a protein phosphatase inhibitor, levamisole
reduced sequestration of P. falciparum trophozoites from
malaria patients' peripheral blood, indicating a potential
effect of dephosphorylation on Plasmodium pathogenesis
[30]. It has been shown that parasite binding to endothe-
lial cells activated MAPK signalling pathways and that the
degree of phosphorylation was proportionate to the avid-
ity of ICAM-1 binding [31]. Also related to the cytoadher-
ence, phosphorylation of major erythrocyte proteins such
as ankyrin and band 4.1 and 4.9 proteins can weaken the
rigidity of the cytoskeleton thus reducing the binding effi-
ciency of the infected erythrocyte [32].
It has been suggested that there is a correlation between
parasite clones of different antigenic variants and cytoad-
herence, rosette formation and pathogenesis. These have
led to studies on the diversity of these properties in P. fal-
ciparum isolates. One example is the line IT4/25/5 and its
derivates [33]. ItG, A4 and C24 are representatives of par-
asite clones selected on C32 amelanotic melanoma cells
(CD36) and HUVEC (ICAM-1), followed by sub-cloning.
These three parasite clones have distinctive cytoadherence
properties namely ItG binds strongly to ICAM-1 and to
CD36, A4 binds strongly to CD36 and to ICAM-1, and
C24 binds strongly to CD36 only. Another unrelated par-
asite line 3D7 is a low binding strain, which shows some
binding to CD36 (although it can be selected for other
binding specificities). It is clear that different parasite iso-
lates have different binding phenotypes, but the mole-
cules involved in adhesion and interaction with the host
are still poorly understood. Moreover, very little is known
about the phosphorylation status of the proteins involvedPage 2 of 16
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teomic analysis of parasite isolates with different adhe-
sion properties found several changes in two-dimensional
electrophoresis profiles in the protein isoelectric point
(pI), consistent with protein phosphorylation as adding
phosphoryl groups to a polypeptide chain supplies a neg-
ative charge to a protein [34], but the extent and dynamic
changes of phosphorylation status have not been system-
atically studied. As a baseline for future studies, the
changes in the phosphoproteome of different parasite
lines at different stages of the asexual erythrocytic cycle
were studied.
Methods
Plasmodium culture
Plasmodium falciparum isolates used in this study were: ItG
[33,35] C24 [33], and 3D7 [36,37]. Parasites were cul-
tured in vitro in group O+ human erythrocytes using previ-
ously described conditions [38]. Briefly, parasites were
cultured in RPMI 1640 medium (supplemented with 37.5
mM HEPES, 7 mM D-glucose, 6 mM NaOH, 25 μg ml-1
gentamicin sulphate, 2 mM L-glutamine and 10% human
serum) at a pH of 7.2 in a gas mixture of 96% nitrogen,
3% carbon dioxide and 1% oxygen. To minimize the
effect of antigenic switching in culture, a batch of stabi-
lates was prepared from post-selection cultures and used
for no more than three weeks. To obtain specific lifecycle
stages of P. falciparum, 5% sorbitol treatment or Plasmagel
flotation was used. For this study, the trophozoites were
obtained 24 to 32 hours after invasion and ring stages
were obtained 6–10 hours after invasion.
Metabolic labelling and fluorography
Parasites were synchronized with 5% sorbitol and left to
grow to the trophozoite stage (28 hours after invasion).
The parasitaemia was adjusted to 10% and cells washed
with serum-free RPMI 1640 medium without methionine
three times. In vitro metabolic labelling was carried out in
RPMI medium lacking methionine, [35S] methionine was
used at a concentration of 50 μCi ml-1. The culture was
gassed and incubated at 37°C for four hours. The reaction
was then stopped by centrifugation to remove radioiso-
topes. The labelled parasites were lysed as described previ-
ously and the Tris-insoluble pellet was subjected to 2D
electrophoresis with pH 4–7 and 12.5% SDS PAGE. After
electrophoresis, the gel was fixed and stained with
Coomassie brilliant blue, immersed in Amplify (Amer-
sham) for 30 min and dried for fluorography.
Two-dimensional electrophoresis (2-DE) and 
immunoblotting
Two-dimensional electrophoresis was carried out accord-
ing to Nirmalan et al [39]. Briefly, synchronized parasite
culture was incubated in 0.05% saponin for 10 min in PBS
on ice to lyse erythrocytes. The lysate was collected by cen-
trifugation at 10,000 × g for 5 min and washed three times
with 10 mM Tris-HCl pH 7.4 with 1 × protease inhibitor
cocktail (Roche). The whole lysate was then solubilized in
2-DE rehydration buffer [8 M urea, 2 M thiourea, 2%
CHAPS, 65 mM dithiothreitol (DTT), and 0.5%
ampholyte pH 4–7 or 3–10]. The sample was vortexed
and sonicated on ice 10 times for 5 seconds followed by
centrifugation at 15,000 × g for 10 min. The supernatant
was subjected to 2-DE and the isoelectric focusing (IEF)
was run on precast Amersham 11 cm pH 3–10 immo-
biline Drystrip gels using IPG phor IEF Unit (Amersham).
The running programme consists of 10 h for 30 V, 40 min
for 200 V, 1 h for 500 V, 4 h for 2,000 V and finally 8 h for
8,000 V. The voltage was increased gradually until a total
of 80,000 vh was reached. The focused strips were equili-
brated in 10 ml equilibration solution (50 mM Tris-HCl,
pH 6.8, 6 M urea, 30% glycerol, 2% SDS) with reducing
agent of 1% DTT for 10 min, and 10 ml equilibration
solution with 4.5% iodoacetamide for another 10 min.
The strips were then washed twice briefly with 1× SDS gel
running buffer and loaded on 10 or 12.5% SDS-PAGE gels
for second dimension separation. The gels were run at
constant current 40 mA in a Laemmli's buffer system until
the dye front reached the bottom of the gel [40]. For 2D
immunoblots, 2D gels were transferred electrophoreti-
cally to Hybond ECL nitrocellulose (Amersham GE
Healthcare UK). The membranes were blocked with
blocking buffer (Sigma UK) at room temperature for 30
min before being probed with the anti-phosphorylated
tyrosine (diluted 1/2,000 in blocking buffer, Cell Signal-
ling) or anti-phosphorylated serine/theronine antibody
(diluted 1/2,000 in blocking buffer, Qiagen) at 4°C, over-
night. The membrane was washed six times in Tris/saline/
Tween (TST: 0.01 M Tris pH 8.5/0.15 M NaCl/0.1%
Tween 20) for 10 minutes each time. Goat anti-mouse IgG
(H+L) horseradish peroxidase conjugate (Nordic 1/2,000)
was used to localize antibody-antigen complexes. The blot
was developed for chemi-luminescence signals using
Lumigen Solution (Amersham GE Healthcare, UK) and
the results viewed by fluorography.
Phosphatase treatment and purification of 
phosphorylated proteins
PhosProtein Purification Kit (Qiagen, Germany) was used
to purify phosphorylated proteins from normal RBC and
ItG infected pRBC according to the manufacturer's
instructions. Briefly, 30 hours after invasion, pRBC were
enriched by Plasmagel gel flotation from 250 ml culture
(5 × 175 cm2 culture flasks with 10% parasitaemia), to
give a packed pRBC pellet of 2.5 ml. Normal RBCs were
cultured under the same conditions for at least two days.
The pRBC or RBCs were washed with culture medium
three times followed by the hypotonic lysis of integrated
pRBC or RBC. The lysates were washed extensively with 50
mM Tris-HCl, pH 7.5, and cold saline to remove haemo-
globin, all these washing buffers contained 1× proteanase
inhibitor (complete mini, Roche, Germany). For phos-Page 3 of 16
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lized in protein lysis buffer (2 M urea, 2% CHAPS, 25 mM
Tris-base, pH 7.5), half of each sample was treated with 10
units (in 10 μl) Shrimp Alkaline Phosphatase (SAP) or
equal volume of 1 × enzyme storage buffer as a control,
and incubated for 10–15 min at 37°C. Subsequent pro-
tein purification followed the manufacturer's instructions.
Phosphorylated proteins eluted from the column were
precipitated with 80% acetone/20% TCA in a ratio of 1:1
at -20°C overnight. The proteins were recovered by cen-
trifugation at 15,000 × g for 20 min at 4°C, washed with
90% ice-cold acetone twice and re-suspended in SDS sam-
ple buffer, boiled for 5 min prior to 1D SDS-PAGE electro-
phoresis.
Protein in gel digestion for MALDI and LC/MS/MS
Spot picking of phosphorylated proteins in 2D gels was
guided by immunoblot images on duplicate gels.
Enriched phosphorylated proteins were separated by 1D
SDS-PAGE and excized into 34 slices. In gel digestion was
performed as described previously [25], the excized pro-
tein was put into an Eppendorf Ultra Pure 1.5 ml centri-
fuge tube and cut into 1 mm3 cubes. The gel slices were
dehydrated by the addition of 100 μl of 50% (v/v) ace-
tonitrile/water and incubated at room temperature for 10
minutes. The dehydrant was then replaced by 100 μl of
ammonium bicarbonate (50 mM) and incubated again at
room temperature for 10 min. These last two steps were
then repeated. The gel slices were dehydrated again with
100 μl of 50% acetonitrile for 10 min and dehydrated
slices were incubated in 10 – 20 μl of sequence grade
trypsin (Promega) (10 μg/ml) for 18 hours at 37°C. The
supernatant was retained and the gel pellet treated with 20
μl of 70% acetonitrile (v/v in water) for 60 minutes at
room temperature. The supernatant from this step was
then removed and pooled with the previous supernatant.
The combined supernatant was dried in a rotational vac-
uum concentrator (RVC2–18), resuspended in 15 μl
water, dried again and resuspended in 15 μl of 0.1% for-
mic acid (in water).
MALDI-TOF mass spectrometry
Samples from the in gel digestion were loaded in a sand-
wich manner with 1% cyano-4-hydroxycin-namic acid
(Sigma) in 50% acetonitrile and 0.05% trifluoroacetic acid
(TFA) onto a stainless steel target. High-resolution spectra
were obtained using a Axima-CFR plus MALDI TOF instru-
ment (Kratos Analytical, Manchester, UK) in reflectron
mode. External calibration was performed using a mixed
three point standard adjacent to the samples [25]. Acquisi-
tion and data processing are controlled by Launchpad soft-
ware (Kratos Analytical, Manchester, UK).
Protein identification was performed by sending trypsin
digested peptide masses to the P. falciparum and human
databases of National Centre for Biotechnology Informa-
tion (NCBI) using the MASCOT (Matrix Science) Peptide
Mass Fingerprinting programme. Fixed carbamidomethyl
modification and variable phosphorylation modifica-
tions were considered as parameters for the search pro-
gramme. The mono-isotopic masses were used and the
mass tolerance was set to 0.5 Da.
Nanoflow LC/MS/MS analysis and database searching
The tryptic peptides were solubilized in 0.5% formic acid
and were separated by nanoflow high-performance liquid
chromatography on a C18 reverse phase column (Dionex
Ultimate 3000) and elution was performed with a contin-
uous linear gradient of 50% acetonitrile for 30 min. The
eluates were analysed by online LC-MS/MS by using an
LTQ ion-trap mass spectrometer (Thermo Finnigan). The
resulting MS/MS spectra were submitted to TurboSequest
Bioworks version 3.1 and the individual spectra was
merged into an mgf file before sending to MASCOT (v2.2)
for searching. Searching was against NCBI P. falciparum
and human databases and was performed using fixed car-
bamidomethyl and variable phosphorylation modifica-
tions. Peptide tolerance was set 0.8 Da, MS/MS tolerance
was set 0.5 Da. Phosphorylated protein identities were
considered significant if the protein score was over the
95% confidence limit and at least one phosphorylated site
was unambiguously identified when a phosphorylated
residue existed (matched) y- or b- ions in the peak lists of
the fragment ions [providing evidence of observed neutral
loss of H3PO4 from the precursor or identified intact phos-
phorylated residues of Serine (pS), Threonine (pT) and
Tyrosine (pY)]. If the protein score reached a significant
level but the ion score of phosphorylated peptide was
under the 95% confidence limit, these were referred to as
potential-phosphorylated proteins.
Results
As reported previously [34], using a sensitive in vivo labe-
ling technique together with 2D electrophoresis revealed
a number of changes in P. falciparum protein profiles from
the pRBC of different parasite lines (Additional file 1).
These changes were not limited to proteins from parasite
source, but were also found in host proteins in the eryth-
rocyte, varying during erythrocytic development of the
malaria parasite e.g., PI changes of human tropomycin
between ring and trophozoite stage (Figure 1). To map the
phosphorylated proteins of pRBC in 2D gels, specific anti-
bodies to phosphorylated amino acids (tyrosine and ser-
ine/threonine) were used to probe total pRBC lysates
from a developmental series. As shown in Figures 2 and
Figure 3, P. falciparum infection increased protein phos-
phorylation along with the developmental time course.
There were approximately 50 protein spots that reacted
positively with anti-serine/threonine antibodies and 4–5
groups of spots that extended horizontally like a family ofPage 4 of 16
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size classes for phosphorylated tyrosine proteins were 95,
60, 50 and 30 kDa and for phosphorylated serine/threo-
nine were 120, 95, 60, 50, 43, 40 and 30 kDa. The major
difference between ItG and C24 was the delayed appear-
ance of a set of phosphorylated tyrosine proteins with
molecular weight from 70 to 95 kDa, such that they
appeared in ItG at 22 hours post-invasion and appeared in
C24 at 30 hours. There were many low abundant proteins
with pI changes in both strains, especially in phosphor-
ylated serine/threonine, but it was difficult to view them
in stained gels. The phosphorylation antibodies also rec-
ognized protein spots of 30, 45 and 95 kDa on non-
infected erythrocytes (see Additional file 2) indicating that
phospho-proteins are present in normal RBC as well (see
below). The results indicated that parasite infection pro-
duced major phosphorylation changes in RBC irrespective
of the stage. The majority of the proteins that reacted with
anti-phosphorylated serine/threonine antibodies were
identified by using MALDI-TOF and MASCOT search with
phosphorylation modifications. Figure 4 indicates the
proteins identified with significant scores and details of
these proteins are listed in Table 1.
To improve the sensitivity of detection, phosphorylated
proteins purified/enriched by affinity chromatography
techniques were separated by 1D SDS-PAGE and identi-
fied by nano-flow LC/MS/MS. Figure 5 shows the gel
images of the proteins treated with either SAP or mock
buffer and then subjected to a PhosProtein Purification
column (Qiagen). The phosphorylated proteins were
eluted after extensive washing, precipitated and separated
Table 1: Details of proteins identified from Figure 4
Protein No. Accession Number Protein name Mol. wt PI Peptide identified1 Score
1. (AAP72014) Apolipoprotein H 37499 8.37 10 145
2. NP_702487 Glyceraldehyde-3-phosphate dehydrogenase 37068 7.59 16 127
3. P10988 Actin-1 (Plasmodium) P10988 42044 5.27 12 123
4. NP_001107609 Erythrocyte membrane protein band 4.9 isoform 43118 8.87 15* 112
5. XP_001352096 Phosphoglycerate kinase 45569 7.63 15 110
6. AAV38387 Adenylate kinase 1 21735 8.73 11 108
7. CAB45236 catalase 59947 6.90 17 105
8. XP_001347854 GTP-binding nuclear protein ran/tc4 24974 7.72 23* 98
9. C3HU complement C3 precursor 188585 6.02 23* 95
10. XP_001352093 s-adenosylmethionine synthetase, putative 45272 6.28 19* 91
11. 1K1K_B Carbonmonoxyhemoglobin C 15970 7.98 12* 88
12. NP_705453 Elonation factor 1 alpha 49156 9.12 18, 88
13. BAB17688 Heat Shock Protein hsp70homologue pfhsp70-3 71945 5.90 30* 84
14. AAD29608 Kappa 1 immunoglobulin light chain 26181 5.72 12* 78
15. XP_001350775 Calcyclin binding protein, putative 30547 8.36 10 73
16. 1605217A Ig gamma 1 25556 7.18 9 71
17. XP_001347438 Pf-hsp60 62911 6.71 24* 66
18. 1XQ9_A Chain A phosphoglycerate mutase 29891 8.31 23* 57
Note: 1. * = phosphorylated peptides identifiedPage 5 of 16
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LC/MS/MS analysis. When the whole pRBC lysate was
pre-treated with phosphatase, the level and extent of pro-
teins seen on the gel (lane 2) and therefore available for
affinity purification was greatly reduced (NB: equal
amounts of proteins were loaded on the affinity column).
34 bands were excised from lane 1 and the proteins iden-
tified represent a shotgun phosphoproteome of ItG tro-
phozoites. All the peptide ions generated from LC/MS/MS
were searched against NCBI databases using MASCOT
search with and without phosphorylation modifications.
The proteins identified using searches including the phos-
phorylation modifications are listed in Additional file 3
(P. falciparum proteins from ItG-pRBC) and Additional
file 4 (human erythrocyte proteins from ItG-pRBC). Addi-
tional file 5 contains the list of proteins identified from
non-infected RBC. They include both confirmed and
potential phosphorylated proteins. There were 170 P. fal-
ciparum proteins and 77 host proteins from purified ItG-
pRBC phosphorylated protein pool, whereas in non-
infected RBC, only 48 proteins were identified in the
phosphorylated protein pool. To unambiguously identify
phosphorylated peptides with phosphorylation sites, the
phospho-peptides with significant ion score were further
extracted to investigate their phosphorylation sites. These
Detail from a 2D gel image of proteins from P. falciparum 3D7 line showing changes in pI between ing and trophozoite stages of pRBCFigure 1
Detail from a 2D gel image of proteins from P. falci-
parum 3D7 line showing changes in pI between ring 
and trophozoite stages of pRBC. The Tris-insoluble 3D7 
pRBC pellets of ring stage and trophozoite stage were 
extracted and separated on 2D electrophoresis on pH 4–7 
IEF strips followed by 12.5% SDS-PAGE. The gels were 
stained with Coomassie blue. The indicated protein was 
identified as human tropomycin by MALDI-TOF mass spec-
trometry.
3D7
Ring stage
3D7
Trophozoite stage
Enhanced chemiluminescence images of immunoblots of phosphorylated serine/threonine proteins of different parasite lines at different tim  points on 2D gelsFigure 2
Enhanced chemiluminescence images of immunoblots of phosphorylated serine/threonine proteins of different 
parasite lines at different time points on 2D gels. C24 and ItG parasites were synchronized by double sorbitol lysis and 
proteins extracted at the time points indicated after parasite invasion. The Tris-insoluble pRBC pellets were extracted and sep-
arated on 2D electrophoresis on pH 4–7 IEF strips followed by 12.5% SDS-PAGE. The gels were transferred on to nitrocellu-
lose paper, and probed with antibodies to phosphorylated serine/threonine.Page 6 of 16
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By using phosphorylation of serine/threonine and tyro-
sine as variable modifications, the selection criteria con-
tains not only the total protein scores that reached a
significant level, but also that protein hits included at least
one significantly recognized phosphorylation site, giving
further evidence in addition to their purification by affin-
ity techniques for their phosphorylation status.
GO slim software was used to classify these proteins into
three categories: biological processes, cell components
and molecular functions, producing three charts showing
the percentage of proteins in specific categories (see Addi-
tional file 6). The height of each column indicates the
numbers of proteins in each category, with different col-
ours representing the proteins from the human host
(blue) or the parasite (red).
Discussion
The shotgun phosphoproteome of ItG-trophozoite pRBC
revealed a total of 247 potential phosphorylated proteins
with phosphorylated serine/threonine proteins (66.3%)
more abundant than phosphorylated tyrosine proteins
(33.7%). Most proteins identified by immune-blotting
and 2D gel based MALDI-TOF techniques overlapped
with proteins identified by affinity enrichment and LC/
MS/MS analysis, supporting the specificity of techniques
used. This is also indicated by the absence of abundant
proteins in 2D gels (e.g. Pf-Enolase, Pf-Ornithine ami-
notransferase, human paraoxonase), indicated that the
affinity chromatography technique selectively enriched a
subset of proteins, ruling out general contamination of
the samples, although this does not rule out a low-level of
contamination.
Within the search algorithm variable modifications can be
a powerful means of finding a match. MASCOT tests all
possible arrangements of variable modifications to find
the best match. For example, when Phosphorylation (Y) is
selected, and a peptide contains 2 tyrosines, MASCOT will
test for a match with the experimental data for that pep-
tide containing 0, 1 or 2, tyrosine phosphorylation resi-
dues. Detection of phosphorylation is complicated
because of site heterogeneity and the possibility of three
fragmentation channels (intact fragments; neutral loss of
HPO3 (80 Da); neutral loss of H3PO4 (98 Da). In MAS-
COT (v2.2), phosphorylated S, T and Y modification adds
80 Da, but whereas pY always stays intact in the spectrum,
pS and pT can either stay intact or can lose 98 Da or occa-
sionally 80 Da http://matrixscience/help/
pt_mods_help.html. In MS/MS ions search, confidence
that a protein has been identified correctly comes largely
from multiple matches to peptides from the same protein.
For a suspected phospho-peptide, the calculated monoi-
Enhanced Chemiluminescence images of immunoblots of phosphorylated tyrosine proteins of different parasite lines at differ-e t tim  points on 2D gelsFigure 3
Enhanced Chemiluminescence images of immunoblots of phosphorylated tyrosine proteins of different para-
site lines at different time points on 2D gels. C24 and ItG parasites were synchronized by double sorbitol lysis and pro-
teins extracted at the time points indicated after parasite invasion. The Tris-insoluble pRBC pellets were extracted and 
separated on 2D electrophoresis on pH 4–7 IEF strips followed by 12.5% SDS-PAGE. The gels were transferred on to nitrocel-
lulose paper, and probed with antibodies to phosphorylated tyrosine.Page 7 of 16
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due(s) with individual ion scores that reach a significant
level (Table 2). The potential phospho-protein 'hits'
(Additional file 3, 4 and 5) were also included where
MASCOT has identified enriched proteins with phospho-
rylation modifications, but their ion score of individual
phospho-peptides failed to reach a significant score level.
Immunoblotting of various erythrocytic stages suggested
that serine/threonine phosphorylation takes place early in
the erythrocytic cycle as the phosphoproteome at 10 hours
after invasion was very similar to that at 30 hours after inva-
sion (Figure 2). However, if comparing immunoblots of
Figure 2 and 3 with normal RBC (Additional file 2), the
reaction was dramatically increased indicating that malaria
parasite infection induced pRBC phosphorylation. 2D
immunoblotting of phosphorylated tyrosine was relatively
weaker compared to that of serine/threonine, consistent
with our LC/MS/MS data and the general observation that
phosphorylated serine/threonine proteins are abundant
and phosphorylated tyrosine is relatively rare, for example
in yeast, in human cells [41] and in bacterium [42]. There
was an indication of changes on tyrosine phospho-proteins
around 80–95 kDa in the trophozoite stage (Figure 3),
between ICAM-1 binding (ItG) and non-binding (C24)
parasite lines. However we failed to confirm their phospho-
rylation status due to the limited amount of proteins recov-
ered from protein spots of 2D gels. In the gel-based study
using MALDI-TOF, only two human proteins were signifi-
cantly identified around 80–95 kDa, therefore we extracted
the data from Additional files 3 and 4 which were obtained
from phospho-protein enrichment by affinity chromatog-
Phospho-proteins separated by 2D gel electrophoresis of ItG trophozoite pRBC and positively stained by anti-phosphorylated serine/threonine at 22 hours after invasionFigure 4
Phospho-proteins separated by 2D gel electrophoresis of ItG trophozoite pRBC and positively stained by anti-
phosphorylated serine/threonine at 22 hours after invasion. The Tris-insoluble pRBC pellets were extracted and sepa-
rated on 2-DE followed by immunoblotting. The duplicate gel stained with Coomassie blue was used to excise the correspond-
ing protein spots and identify the proteins by MALDI-TOF or LC/MS/MS. All protein identities achieved significant protein 
scores in MASCOT search results.
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nificantly identified with molecular weights from 75–100
kDa (Table 3). 14 proteins were identified as tyrosine phos-
phorylated proteins by using LC/MS/MS, however it is not
possible to say whether they are those seen in the 2D
Immunoblot in Figure 3 although the molecular weight
and positions in the gel would support this. Further more
specific studies will be required to differentiate the phos-
phorylation status in parasite strains with different binding
properties and to test if internal phosphorylation contrib-
utes to cytoadherence.
The 30 kDa band seen with both anti-phospho tyrosine
and serine/threonine antibodies shows some back-
ground, reacting with the secondary antibody only, but
the intensity and extent of the reaction was greatly
increased on the addition of the primary antibody. More-
over, it contains several known phospho-proteins, for
example, calcyclin binding protein (gi23509063), ade-
nylate kinase 2 (gi32394417), vesicle-associated mem-
brane protein (gi23497447) and phosphoethanolamine
N-methyltransferase (gi38018254). Some parasite eryth-
rocyte membrane proteins such rifin (gi23613367) and
stevor (gi23498318) have also seen when searching using
MASCOT with phosphorylation modifications but they
did not reach a significant level.
Many phosphorylated proteins seen in this study using affin-
ity enrichment and LC/MS/MS showed very high MASCOT
scores and frequently appeared in the search results suggest-
ing high abundance or multiple family members. Since the
proteins were extracted from Tris-insoluble pellets of pRBC,
this pool includes proteins of outer and inner membranes,
cytoskeleton and nuclear proteins. One of these proteins
from P. falciparum is from the family of cytoadherence linked
asexual proteins (CLAG), with five members of this family
identified in phosphorylated protein pool namely CLAG 2,
8, 9 and RhopH1/Clag3.1, RhopH1/Clag3.2. These proteins
are the products of clag gene family and have been proposed
as being involved in cellular interactions [43,44]. Other
abundant phosphorylated proteins of interest were DNAJ
protein (PFE1605w), which is a co-chaperone of HSP70 in E.
coli where it forms an operon with DnaK (HSP70) to regulate
its ATPase activity [45]. In P. falciparum DnaJ is also referred
to as RESA (in Additional file 3) and is predicted to be
exported outside the parasite as it contains a PEXEL motif
[46]. ISWI protein homologue (PFF1185w) is a chromatin-
remodelling protein involved in gene expression and the
maintenance of higher order chromatin structure [47] and
possesses variable binding functions to DNA and proteins.
There were a number of heat shock phospho-proteins,
including: HSP101 (PF11_0175), HSP86 (PF07_0029),
HSP78 (PFI0875w), HSP70 (PFI0875w), HSP74
(PF08_0054), HSP60 (PF10_0153) and other proteins with
chaperone activities such as 14-3-3 protein homologue
(MAL8P1.69) and Chaperonin CPN60 (PFL1545c). Molecu-
lar chaperones are a large protein family with roles in unfold-
ing proteins for translocation, assembly and degradation. It
is particularly interesting that most of these proteins are not
only phosphorylated, but also exported [48,49], making
them candidates for communication with the external envi-
ronment. Known phosphorylated proteins found in this
study were protein kinases and phophatases. However, the
numbers and types of these enzymes identified were limited,
which may reflect the situation in vivo that only small
amount of regulatory molecules are present suggesting that
the study of protein kinases or phosphatases in P. falciparum
may need to use specific affinity techniques to produce suit-
able yields [50].
A basic level of phosphorylation was observed in non-
infected erythrocytes with phospho-proteins including spec-
trin, ankyrin, adducin and erythrocyte membrane proteins
4.1 and 4.9. This kind of phosphorylation may be caused by
the age of erythrocytes and in vitro culture, or may be a self-
adjustment by the erythrocyte to maintain its shape and sur-
vival. By subtracting normal erythrocyte data from data
1D gel image of proteins eluted from a phospho-protein purification columnFigure 5
1D gel image of proteins eluted from a phospho-pro-
tein purification column. Lane 1, proteins with mock 
treatment, lane 2 proteins treated with SAP prior to purifica-
tion/enrichment for phospho-proteins. The arrows indicate 
the cutting side and the numbers represent the bands 
excised and processed for LC/MS/MS analysis.
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Malaria Journal 2009, 8:105 http://www.malariajournal.com/content/8/1/105Table 2: The proteins possess significant ion score for phosphorylated peptides with defined phosphorylation sites
Plasmodium falciparum proteins from ItG-pRBCs:
No* Accession no Protein name Phosphorylated peptide sequences MW* Site* Score*
PF1 PFB0100c knob-associated His-rich protein GASTTAGSTTGATTGANAVQSK 69791 T5, S8 103
PF2 PFE0870w transcriptional regulator FAYKSDEDDEGYNK 133456 S5 67
PF3 PF08_0137 hypothetical protein PF08_0137 KGSLGFDSFK 147208 S3 46
PF4 PF10_0159 Glycophorin-binding protein (GBP-130) SVVTEEQKVESDSEK 90077 S11 37
PF6 MAL7P1.38 regulator of chromosome condensation 
protein
INEQSEGSNLPSEQNK 79931 S5 31
PF7 PFL0050c hypothetical protein PFL0050c AVPQNSGSNFDEFLDVK 77525 S8 32
PF5 PFI0265c RhopH3 GLEFYKSSLK 104856 S7 33
PF8 PFD1165w protein kinase, conserved INDPYDYLKSITNQEER 75365 S10 61
PF9 PFE1485w hypothetical protein ETNESIYIK 225530 T2, Y7 45
PF10 PF14_0648 hypothetical protein CDKEIYNLHIK 238305 Y6 36
PF11 PFE1600w hypothetical protein NYSTHENTYPTLK 62720 Y9 49
PF12 PF14_0434 hypothetical protein FSVFDSDDNSEEEIENK 41909 S6, S10 42
IIEVHDNIPSPIIK S10 75
DLNESPKNEPDIVYEEK S5 59
PF13 PF13_0214 elongation factor 1-gamma DDNNNNNNNDADNQHADLLSDDL
AEK
50491 S20 48
PF14 MAL8P1.95 hypothetical protein NLENNEDDETNVGR 37933 T10 44
PF15 PF07_0008 hypothetical protein HYSLGGQPSSSGR 27713 S9 76
NYSLGNLSTGTTSQGSTSSR T11 76
YNTSNLASSSTTESSVSGLNTNEAHV S10 78
NYSLGNLSTGTTSQGSTSSR Y2 S16 58
YNTSNLASSSTTESSVSGLNTNEAHV T12 92
PF16 PFL1005c chromodomain protein NESPQWVEETNIR 30999 S3 55
TGSDEEFEIGDILEIK S3 98
PF17 MAL7P1.174 hypothetical protein DGNDSSSEELDNTNVPTSKPK 37984 S5 63
PF18 PF13_0275 hypothetical protein YGSGSHDHEEEVVEA 32877 S3 35
SSSNSHVESNTFQNK S3 47Page 10 of 16
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Malaria Journal 2009, 8:105 http://www.malariajournal.com/content/8/1/105PF19 XP_001351065.1 RESA-like protein LNTIGNLFEGEK 36224 T3 54
PF20 Q8IKH8_PLAF7 ribosomal protein S3 TGLTSILPDNISVLEPK 24823 S12 46
PF21 PFD0375w hypothetical protein EYMNNILYDQNK 142869 Y2 36
Human proteins in ItG-pRBCs:
Hu1 SPTB1 spectrin beta isoform b KEELGELFAQVPSMGEEGGDADLSIEK 246894 S13 89
Hu2 M28880 Ankyrin LGYISVTDVLK 207138 S5 62
Hu3 BAD92655 Ankyrin 1 isoform 4 variant ITHSPTVSQVTER 208408 S4 55
Hu4 CAA41149 Erythrocyte alpha adducin SPGSPVGEGTGSPPK 81377 S4 47
AAVVTSPPPTTAPHK S6 55
Hu5 AAH56881 ADD2 protein TESVTSGPMSPEGSPSKSPSK 78576 S18 56
SAGPQSQLLASVIAEKSR S17 72
Hu6 AAH04261 Proline rich 7 protein KIVTPFLSR 28986 T4 45
Hu7 MMHUE4 Erythrocyte membrane protein band 4.1 SLDGAAAVDSADR 95750 S1 65
Hu8 C3HU Chain A, Complement Component C3 SGIPIVTSPYQIHFTKTPK 188585 T17 21
Hu9 Q05764 Beta-adducin SPGSPVGEGTGSPPK 81129 S4 89
Hu10 CAH93400 Erythrocyte membrane protein band 4.9 SSSLPAYGR 45600 S3 38
Hu11 AAC50223 Dematin 52 kDa subunit RGAEEEEEEEDDDSGEEMK 45726 S14 50
Hu12 NP_001284 Chloride ion current inducer protein I (Cln) EPVADEEEEDSDDDVEPITEFR 26084 S11 55
FEEESKEPVADEEEEDSDDDVEPITEFR S17 60
Hu13 CAA40340 Glycophorin A SPSDVKPLPSPDTDVPLSSVEIENPETSDQ 14784 S19, T27 43
Hu14 GFHUC Glycophorin C GTEFAESADAALQGDPALQDAGDSSR S25 80
Human proteins from normal RBCs:
RBC1 BAD92652 Spectrin, beta, erythrocytic DASVAEAWLIAQEPYLASGDFGHTVDS
VEK
268238 S27 62
LSSSWESLQPEPSHPY S4 27
RBC2 NP_000338 Spectrin TSPVSLWSR 246468 S2 26
RBC3 NP_976217 Erythrocyte membrane protein band 4.1 VSLLDDTVYECVVEK 71955 Y9 58
SLDGAAAVDSADR S1 81
RBC4 AAL15446 Erythrocyte membrane protein 4.1N TETMTVSSLAIRK 97405 S7
S8
23
Table 2: The proteins possess significant ion score for phosphorylated peptides with defined phosphorylation sites (Continued)Page 11 of 16
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Malaria Journal 2009, 8:105 http://www.malariajournal.com/content/8/1/105RBC5 NP_001969 Erythrocyte membrane protein band 4.9 RGAEEEEEEEDDDSGEEMK 45514 S14 70
RBC6 CAA34611 Alt. ankyrin (variant 2.2) ITHSPTVSQVTER 189011 S4 64
RBC7 NP_054909 Adducin 1 (alpha) isoform c AAVVTSPPPTTAPHK 69985 S6 58
SPGSPVGEGTGSPPK S4 74
RBC8 AAH56881 ADD2 protein TESVTSGPMSPEGSPSKSPSK 78576 S18 54
RBC9 NP_002427 Palmitoylated membrane protein 1 TAELSPFIVFIAPTDQGTQTEALQQLQK 52296 T20 53
RBC10 2GU8_A Chain A, Discovery Of 2-Pyrimidyl-5-
Amidothiophenes As Novel And Potent 
Inhibitors For Akt
TWDLCGTPEYLAPEIILSK 39232 T1 43
RBC12 1BUW_B Chain B, Crystal Structure Of S-Nitroso-
Nitrosyl Hemoglobin A
GTFATLSELHADK 15875 S7 31
RBC13 1DPF_A Chain A, Crystal Structure Of A Mg-Free 
Form Of Rhoa Complexed With Gdp
DQFPAVYVPTVFENYVADIEVDGK 20169 Y7 23
No*: PF = Plasmodium protein; Hu = erythrocyte protein; MW* = protein molecular weight; site* = phosphorylated site identified by MASCOT; 
Score* = All phosphorylated peptide ion scores reached a significant level
Table 2: The proteins possess significant ion score for phosphorylated peptides with defined phosphorylation sites (Continued)Table 3: Phosphoproteins from ItG trophozoites [75–100 kDa (see Fig. 5)]
Accession number Gene name Mol Wt PI Score Phosphorylation Details*
PF10_0159 Glycophorin-binding protein 130 90077 5.08 779 ST2
PF08_0054 Heat shock 70 kDa protein (HSP74) 74754 5.51 444 ST4
BAG09363 Rhoptry complex polypeptide RhopH3 104798 6.25 324 ST3
MAL7P1.38 Regulator of chromosome condensation protein 79931 6.47 323 ST5, Y1
PFL0055c Protein with DNAJ domain 108185 7.04 321 ST1, Y1
CAA28816 PFRESAR2 NID (ring-infected erythrocyte surface antigen precursor) 88816 4.92 181 ST1, Y1
Q8IFM1 Protein kinase 75365 9.08 153 ST8, Y1
PFF0250w RNA binding protein, putative 86204 6.47 146 ST1
Q9GTW3 Glutamic acid-rich protein 80987 4.91 135 Y1
Q25730 Rhoptry associated protein-1 90423 6.69 121 ST20, Y1
Q8IJ23 Polyadenylate-binding protein 108656 8.35 110 Y1
PF11_0175 Heat shock protein 101 103038 9.17 103 ST1, Y1Page 12 of 16
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Q8I5H4 Polyadenylate-binding protein, 97455 8.96 94 ST11
Q8I3I6 Beta adaptin protein 102841 5.53 84 ST2
Q8I0V3 Chaperonin cpn60, mitochondrial 79898 4.93 76 ST2
E71608 ATP-dept. acyl-CoA synthetase (TP) PFB0695c 103277 8.83 63 ST8
PF10_0077 Eukaryotic translation initiation factor 3 subunit 84517 8.26 62 ST1
Q9NIH1 P101/acidic basic repeat antigen 86321 4.81 55 ST1
Q8I635 Hypothetical protein 77525 4.40 414 ST3, Y1
T18421 Hypothetical protein C0140c 89820 6.31 127 ST7, Y1
Q8IL87 Hypothetical protein 77412 9.07 90 ST2, Y1
Q8IL87 Hypothetical protein.- 77412 9.07 81 ST4
Q8I2G1 Hypothetical protein PFI1735c.- 82991 5.46 53 ST3
Host erythrocyte proteins
Accession Gene name MW PI Score Phospho-site
ADDB Beta-adducin (Erythrocyte adducin subunit beta 80854 5.51 1207 ST7, Y1
MMHUE4 Erythrocyte membrane protein 4.1 95750 5.37 591 ST3
Q4VB86 Hypothetical protein (EPB41 protein) 83618 5.52 589 ST3
S18208 Rabphilin-3A-interacting protein 81260 5.67 456 ST7
AAD42222 AF156225 NID: 97567 5.22 382 ST3
ADDA Alpha-adducin 81304 5.60 153 ST11, Y1
CAC18967 Sequence 3 from Patent WO0068693 85082 4.94 143 ST1 Y1
Q53FS6 TNF receptor-associated protein 1 variant 80326 8.05 72 ST3
I2C2 Eukaryotic translation initiation factor 2C 2 97991 9.34 46 ST1
* Phosphorylation details: The phosphorylated proteins were identified because they contained phosphorylated peptides. ST means serine/
threonine, Y means tyrosine
Table 3: Phosphoproteins from ItG trophozoites [75–100 kDa (see Fig. 5)] (Continued)obtained from ItG-pRBC, it was possible to distinguish some
erythrocyte proteins significantly modified by phosphoryla-
tion upon invasion. One interesting protein identified as
phosphorylated host protein in ItG-pRBC is NP_001284,
chloride ion current inducer protein I (Cln), also called chlo-
ride channel regulatory protein. Malaria parasites infection
produces high permeability of erythrocyte membrane to a
large variety of solutes [51]. The altered permeability is pre-
sumed to be due to the activation of endogenous dormant
channels and chloride channels are very important to chan-
nel activity [52]. Our data on the phosphorylation of a chlo-
ride channel protein in response to parasite invasion
supports the possibility that this may contribute to NPPs
[11]. Another interesting host protein is complement com-
ponent 3 (C3) which we found as a phospho-protein specif-
ically after P. falciparum infection. C3 is a component of the
plasma but increases its deposition on red cells and binding
to haemoglobin in children with severe malarial anaemiaPage 13 of 16
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in the regulation of T cell-mediated responses [54]. It
enhances the opsonization of immune complexes by phos-
phorylation due to increased binding to IgG [55]. There have
been reports on the changes of complement system during
malaria infection [56,57] and the contribution of comple-
ment in protective immunity in malaria [58], but little infor-
mation about the phosphorylation states of complement
components and their roles during infection.
Conclusion
This study investigated the phosphorylation status of
pRBC and dynamic changes of protein phosphorylation
using Western-blots on 2D gels and/or phospho-protein
enrichment coupled with high-accuracy mass spectrome-
try. The results have provided us with the basis of phos-
phorylation of RBC and pRBC for future research as well
as identifying some interesting leads for further investiga-
tion of the role of protein phosphorylation in important
parasite processes.
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PI changes of pRBC from different parasite lines. Fluorography of pro-
teins from trophozoite stage pRBC infected with 3D7 and ItG. At 20 hours 
after invasion, parasites were metabolically labelled with 50 μCi/ml [35S] 
methionine for 4 hours. Tris-insoluble pellets of pRBC were separated run 
on pH 4–7 IEF strips followed by 12% SDS-PAGE. Gels were stained with 
Coomassie blue, dried and exposed to X-ray film. Marked boxes show pro-
teins with at least three fold changes between 3D7 and ItG. Enlarged 
images of corresponding boxes showing significant changes in the protein 
profiles. Arrows indicate the relative positions of the spots in different 
lines.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2875-8-105-S1.pdf]
Additional file 2
Immunoblot of normal RBC and secondary antibody control. Immu-
noblot of normal RBC separated by 2DE (using the same conditions as for 
Figures 2 &3) and probed with antibodies to phosphorylated serine/threo-
nine (A) or tyrosine (B). Part C is an immunoblot of Tris-insoluble pellet 
of ItG-infected RBC probed with the secondary antibody only and devel-
oped by ECL.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2875-8-105-S2.pdf]
Additional file 3
Plasmodium falciparum phosphorylated proteins from ItG infected 
erythrocytes. Phosphorylated proteins purified/enriched by affinity chro-
matography techniques were separated by 1D SDS-PAGE and identified 
by nano-flow LC/MS/MS. Additional file 4 contains P. falciparum pro-
teins from ItG-pRBC identified using searches including the phosphoryla-
tion modifications.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2875-8-105-S3.doc]
Additional file 4
Host phosphorylated proteins from ItG infected erythrocytes. Phospho-
rylated proteins purified/enriched by affinity chromatography techniques 
were separated by 1D SDS-PAGE and identified by nano-flow LC/MS/
MS. Additional file 5 contains human phosphorylated proteins from ItG-
pRBC identified using searches including the phosphorylation modifica-
tions.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2875-8-105-S4.doc]
Additional file 5
Phosphorylated proteins of non-infected erythrocytes purified from 
phospho-affinity column. Phosphorylated proteins purified/enriched by 
affinity chromatography techniques were separated by 1D SDS-PAGE and 
identified by nano-flow LC/MS/MS. Additional file 6 contains human 
phosphorylated proteins from normal RBC identified using searches 
including the phosphorylation modifications.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
2875-8-105-S5.doc]
Additional file 6
Gene ontology analysis of serine/threonine and tyrosine phosphor-
ylated proteins. Gene ontology analysis of the serine/threonine and tyro-
sine phosphorylated proteins. A. Functional categories; B. Cellular 
components; C. Biological processes. The different colours indicate human 
(blue) or parasite (red) proteins.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1475-
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